It has been recently described the roles of interferon regulatory factors (IRFs), a family of transcription factors that regulate IFN expression, that play important roles in both innate and adaptive immune responses and the potential of IRF regulators in NAFLD treatment, as recently well described in a comprehensive review conducted by Zhang et al. [26]. This evidence concerns the gene TRIM63 and metabolic dysfunction-associated steatotic liver disease.